38 results
8-K
EX-99.1
CCCC
C4 Therapeutics Inc
8 May 24
C4 Therapeutics Reports First Quarter 2024 Financial Results and Recent Business Highlights
7:07am
, clinical development. Dr. Powers brings over 20 years of leadership experience in clinical development and medical affairs within the hematology
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
their own biases and learning inclusive leadership techniques, to promoting the advancement of leaders from different backgrounds and through … ) Organization, Leadership and Compensation Committee, and (iii) Nominating and Corporate Governance Committee are posted on our website
8-K
CCCC
C4 Therapeutics Inc
8 Mar 24
Departure of Directors or Certain Officers
4:10pm
”), the Organization, Leadership and Compensation Committee (the “Committee”) of the Board of Directors (the “Board”) of C4 Therapeutics, Inc. (the “Company … leadership team, the new exercise price for repriced options is $19.00 per share, which was selected as it was the price per share of the Company’s initial
8-K
EX-99.1
uvroo
20 Nov 23
C4 Therapeutics Strengthens Board of Directors with Owen Hughes Appointment
7:05am
8-K
dhdzodenemea9
5 Sep 23
C4 Therapeutics Announces Chief Financial Officer Succession
4:02pm
8-K
EX-99.1
r1u49a
8 Aug 23
C4 Therapeutics Reports Second Quarter 2023 Financial Results and Recent Business Highlights
7:09am
8-K
EX-99.1
1290nn3tlwbz q387fu
20 Jun 23
C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer
7:11am
8-K
lvm3x64k0p4dgfqck
20 Jun 23
C4 Therapeutics Appoints Leonard Reyno, M.D., as Chief Medical Officer
7:11am
ARS
s51ub35vlgloqalp3
28 Apr 23
Annual report to shareholders
7:03am
PRE 14A
7hzj3
18 Apr 23
Preliminary proxy
7:59am
8-K
xzg7rpuckq0rxpja2m
17 Jun 22
Departure of Directors or Certain Officers
4:05pm